Taxonomic group: bacteria / Firmicutes
(Phylum: Firmicutes)
The structure was elucidated in this paperNCBI PubMed ID: 37479437Publication DOI: 10.1016/j.carbpol.2023.121122Journal NLM ID: 8307156Publisher: Elsevier
Correspondence: F. Pei <fangyipei

126.com>
Institutions: Research Institute of Medicine and Pharmacy, Qiqihar Medical University, Qiqihar, 161006, China, Office of Academic Research, Qiqihar Medical University, Qiqihar 161006, China
Obesity associated with diet and intestinal dysbiosis is a worldwide public health crisis, and exopolysaccharides (EPS) produced by lactic acid bacteria (LAB) have prebiotic potential to ameliorate obesity. Therefore, the present study obtained LAB with the ability to produce high EPS, examined the structure of EPS, and explained its mechanism of alleviating obesity by in vivo and in vitro models. The results showed that Weissella cibaria PFY06 with a high EPS yield was isolated from strawberry juice, and pure polysaccharide (PFY06-EPS) was purified by Sephadex G-100. The structural characteristics of PFY06-EPS showed that the molecular weight was 8.08 × 106 Da and composed of α-(1,6)-D glucosyl residues. An in vitro simulated human colon fermentation test demonstrated that PFY06-EPS increased the abundance of Prevotella and Bacteroides. Cell tests confirmed that PFY06-EPS after fecal fermentation inhibited fat accumulation by promoting the secretion of endogenous gastrointestinal hormones and insulin and inhibiting the secretion of inflammatory factors. Notably, PFY06-EPS reduced weight gain, fat accumulation, inflammatory reactions and insulin resistance in a high-fat diet-induced obesity mouse model and improved glucolipid metabolism. PFY06-EPS intervention reversed obesity-induced microflora disorders, such as reducing the Firmicutes/Bacteroides ratio and increasing butyrate-producing bacteria (Roseburia and Oscillibacter), and reduced endotoxemia to maintain intestinal barrier integrity. Therefore, in vivo and in vitro models showed that PFY06-EPS had potential as a prebiotic that may play an anti-obesity role by improving the function of the gut microbiota.
exopolysaccharide, gut microbiota, obesity, endogenous gastrointestinal hormones, short-chain fatty acids
Structure type: homopolymer ; 8080000
Location inside paper: abstract, p. 121122-4
Compound class: EPS
Methods: gel filtration, 13C NMR, 1H NMR, NMR-2D, ELISA, GC, biological assays, composition analysis, HPLC, statistical analysis, fermentation, RNA sequencing, cell viability assay, histological analysis, cytotoxicity assa
Comments, role: NMR temperature was not specified
NCBI Taxonomy refs (TaxIDs): 137591
Show glycosyltransferases
NMR conditions: in D2O
[as TSV]
13C NMR data:
Linkage Residue C1 C2 C3 C4 C5 C6
aDGlcp 97.5 71.4 73.4 69.5 70.2 65.5
1H NMR data:
Linkage Residue H1 H2 H3 H4 H5 H6
aDGlcp 4.98 3.57 3.71 3.52 3.91 3.75-3.98
1H/13C HSQC data:
Linkage Residue C1/H1 C2/H2 C3/H3 C4/H4 C5/H5 C6/H6
aDGlcp 97.5/4.98 71.4/3.57 73.4/3.71 69.5/3.52 70.2/3.91 65.5/3.75-3.98
1H NMR data:
Linkage | Residue | H1 | H2 | H3 | H4 | H5 | H6 |
| aDGlcp | 4.98 | 3.57 | 3.71 | 3.52 | 3.91 | 3.75 3.98 |
|
13C NMR data:
Linkage | Residue | C1 | C2 | C3 | C4 | C5 | C6 |
| aDGlcp | 97.5 | 71.4 | 73.4 | 69.5 | 70.2 | 65.5 |
|
There is only one chemically distinct structure: